Risk of loco-regional recurrence and distant metastases of patients with invasive breast cancer up to ten years after diagnosis – results from a registry-based study from Germany | BMC Cancer | Full
Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time | British Journal of Cancer
Liquid Biopsy in Breast Cancer: A Comprehensive Review
Follow-Up of Patients with Breast Cancer: Imaging of Local Recurrence and Distant Metastases | SpringerLink
New Strategies in Metastatic Hormone Receptor–Positive Breast Cancer: Searching for Biomarkers to Tailor Endocrine and Other Targeted Therapies | Clinical Cancer Research
Breast cancer recurrence rate not up with autologous fat transfer
Is a comparative clinical trial for breast cancer tumor markers to monitor disease recurrence warranted? A value of information analysis | Journal of Comparative Effectiveness Research
Signatera Overview | Natera
Longterm Followup of Breast Cancer Patients Julie R
Tumor Markers of Breast Cancer: Role in Early Diagnosis, Monitoring Response to Therapy and Determination of Prognosis : Science and Education Publishing
Monitoring in breast cancer patients by Elecsys CA 15-3. | Download Scientific Diagram
08.01.2021: Poster - High content in vitro cell monitoring effects of adjuvant chemotherapy in breast cancer and cancer treatment-related cardiomyopathy
Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer - EBioMedicine
Monitoring breast cancer progression and response to therapy using... | Download Scientific Diagram
Does Ki-67 Predict Recurrence Risk in Early Stage Breast Cancer? | Physician's Weekly
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer | Science Translational Medicine
Circulating tumor DNA analysis in breast cancer: Is it ready for prime-time? - Cancer Treatment Reviews
Thermoradiotherapy Found to be Safe, Effective in Patients with Recurrent Breast Cancer – Consult QD
Breast cancer recurrence monitoring according to tumor subtypes: Role of serum tumor markers CA15-3 and CEA using Radioimmunoass
PLOS ONE: Analysis of Cancer Mutation Signatures in Blood by a Novel Ultra-Sensitive Assay: Monitoring of Therapy or Recurrence in Non-Metastatic Breast Cancer
The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS) | BMJ Open
Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence | Clinical Cancer Research
Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect
:max_bytes(150000):strip_icc()/breast-cancer-tumor-markers-and-tumor-marker-tests-4301102-30358af146c64584b345c51499c0d70c.png "Breast Cancer Tumor-Marker Tests")
Breast Cancer Tumor-Marker Tests
Breast cancer biomarkers tag
